FDA inspection

Cardinal Health Manufacturing Services B.V.: FDA inspection ending May 27, 2004

FDA inspection 328883 · Voluntary Action Indicated (VAI) · Humacao, PR

Key facts

Inspection ID 328883
Firm Cardinal Health Manufacturing Services B.V.
FEI number 2650094
Address Rd 925 Km. 6.1
City Humacao
State PR
ZIP 00792
Fiscal year 2004
Inspection end date May 27, 2004
Classification Voluntary Action Indicated (VAI)
Project area Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation
Product type Devices, Drugs

At a glance

  • 10–99 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections